Guanfacine to Treat Borderline Personality Disorder

NCT00358969 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: guanfacine (Tenex)

Sponsor

Icahn School of Medicine at Mount Sinai